Momentum Trades

Friday, January 17, 2014 (PM)

January 2014 | Members

Do not risk more than 5% of your trading account on any one trade but do try to take ALL of the trades.  Please remember, ALL “Exit Targets” and “Stop Targets” are targets.  You should not have any “Hard Stops” entered to close any tradesor “Exit Orders” in your brokerage account unless we list one.  We will send out a “Profit Alert” or “New Trade” if we want you to close a position OR if a new trade comes out.  Otherwise, follow instructions at all times in the 9am and 1pm updates.  Also, we will usually give you a heads-up if we think we are going to send an email outside of these time frames.  Closed Trades for 2014: 9-0- the Weekly Wrap is 4-0 for 2014 (89-7 since 2011) and is designed for traders that want to use options with less risk.

1:00pm (EST)

New Trade!!! 

Ariad Pharmaceuticals (ARIA, $6.98, up $0.24)

Buy to OPEN February 8 calls (ARIA140222C00008000, $0.45, up $0.05)

Action:  We said a pop past $7 would entice us to get back into a trade on Ariad.  Our first trade made us 56%.  We have a Price Target of $13 for the stock over the next 3-6 months with a pop to $10 by mid-February.

 

Current Trades

Aruba Networks (ARUN, $21.13, up $0.53)

February 21 calls (ARUN140222C00021000, $1.50, up $0.35)

Entry Price:  $0.55 (1/14/2014)

Exit Target:  $1.10 (closed a third @ $0.85 on 1/15/14)

Return:  133%

Stop Target:  70 cents (Stop Limit)

Action:  We wanted to see a close above $20.75-$21 today and shares have reached a peak of $$21.50.  While we should close another third of the trade, we are going to remain aggressive with Aruba as we believe shares could push $22-$24 over the near-term.

 

SLM (SLM, $24.77, down $2.37)

February 27 calls (SLM140222C00027000, $0.05, down $0.65)

Entry Price:  $0.60 (1/13/2014)

Exit Target:  $1.20

Return:  -92%

Stop Target:  None

Action:  We should have trusted our instincts yesterday as we said we were a little nervous the company would report earnings on Thursday with a conference call today.  Obviously, management has said nothing good as shares have stayed near session lows.  We still have 4 weeks before these options expire but we got this one wrong.  We could save the $100 we have left in premium but we will let it ride and place the trade on HOLD.  We only need a close above $27.60 by mid-February to breakeven on the trade but $25 will likely serve as resistance going forward.

 

Sony (SNE, $17.20, down $0.01)

February 19 calls (SNE140222C00019000, $0.20, flat)

Entry Price:  $0.45 (1/8/2014)

Exit Target:  $0.90

Return:  -56%

Stop Target:  None

 

April 20 calls (SNE140419C00020000, $0.35, flat)

Entry Price:  $0.55 (1/8/2014)

Exit Target:  $1.10

Return:  -36%

Stop Target:  None

Action:  Support is at $17 with the possibility of a test to $16.50.  We would like to see a close above $17.50 today.

 

Galena Biopharma (GALE, $7.04, down $0.44)

February 6 calls (GALE140222C00006000, $1.30, down $0.40)

Entry Price:  $0.40 (1/7/2014)

Exit Target:  $2.50-$3 (closed a third @ $0.90 on 1/10/14)

Return:  192%

Stop Target:  80 cents (Stop Limit)

Action:  Shares tested support at $6.75 and will be trying to hold $7 into the close.

 

General Electric (GE, $26.50, down $0.70)

March 28 calls (GE140322C00028000, $0.15, down $0.25)

Entry Price:  $0.45 (1/7/2014)

Exit Target:  $0.90

Return:  -67%

Stop Target:  None

Action:  GE is getting punished for a decent quarter and there is further risk to $26-$25.50.  These are March calls and we have 63 days before they expire.  Our breakeven point is $28.45 and shares should hold support with the dividend at 3.3% following today’s dip.  Shares could still reach $29-$20 on a move back above $27.50 and would be enough for a double from our original entry price.

Side Note:  We don’t like “leveraging” down a position to lower our cost basis as some newsletters try this trick and also count a rebound twice if they take half profits higher than the averaged down price.  Our feelings are if we are wrong about a trade once then we can admit we got it wrong.  We don’t like being wrong twice.  Additionally, sometimes other newsletters will average down the trade and report it as one loss instead of 2.  However, MOST newsletters don’t have Track Records and the shady ones that do use these practices to tout their returns.

 

PulteGroup (PHM, $19.39, down $0.30)

February 22 calls (PHM140222C00022000, $0.20, flat)

Entry Price:  $0.40 (1/3/14)

Exit Target:  $0.80

Return:  -50%

Stop Target:  None

Action:  The 20-day MA is at $19.08.  PulteGroup announces their numbers on January 30.

 

Other 2014 Portfolio OPEN positions (0):  These are trades that are still open in the portfolio but are down over 50%.  They have longer expiration dates and are on “hold” but are not worth mentioning until they turn around.  This means we would not open any new positions.  We are still keeping track of the trades and we will record the results, accordingly, when we close them or if the options expire.  Click on the 2013Portfolio link in the Members Area to view ALL open/ closed trades.

 

WATCH LIST SECTION

These trades are NOT recommendations.  They are trades that we like but have not added to the portfolio as an official recommendation because of market conditions or because we are waiting for better entry prices.  We try not to have more than 12-15 open trades at any one time which is why we created a Watch List.  We will not list entry prices because these stocks are on the verge of breaking out or they could sell off but these are the trades we are watching as new candidates.

We will update this section on Tuesday with some fresh ideas.

Scroll to Top